Based on experimental evidence of the antinociceptive action of endocannabinoids and their role in the modulation of trigeminovascular system activation, we hypothesized that the endocannabinoid system may be dysfunctional in chronic migraine (CM). We examined whether the concentrations of N-arachidonoylethanolamide (anandamide, AEA), palmitoylethanolamide (PEA), and 2-arachidonoylglycerol (2-AG) in the CSF of patients with CM and with probable CM and probable analgesic-overuse headache (PCM + PAOH) are altered compared with control subjects. The above endocannabinoids were measured by high-performance liquid chromatography ( HPLC), and quantified by isotope dilution gas-chromatography/mass-spectrometry. Calcitonin gene-related peptide (CGRP) levels were also determined by RIA method and the end products of nitric oxide (NO), the nitrites, by HPLC. CSF concentrations of AEA were significantly lower and those of PEA slightly but significantly higher both in patients with CM and PCM + PAOH than in nonmigraineur controls (p < 0.01 and p < 0.02, respectively). A negative correlation was found between AEA and CGRP levels in CM and PCM + PAOH patients (r=0.59, p < 0.01 and r=-0.65, p < 0.007; respectively). A similar trend was observed between this endocannabinoid and nitrite levels. Reduced levels of AEA in the CSF of CM and PCM + PAOH patients may reflect an impairment of the endocannabinoid system in these patients, which may contribute to chronic head pain and seem to be related to increased CGRP and NO production. These findings support the potential role of the cannabinoid (CB) 1 receptor as a possible therapeutic target in CM.

Endocannabinoids in chronic migraine: CSF findings suggest a system failure / P., Sarchielli; Pini, Luigi Alberto; F., Coppola; C., Rossi; A., Baldi; M. L., Mancini; P., Calabresi. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - STAMPA. - 32:6(2007), pp. 1384-1390. [10.1038/sj.npp.1301246]

Endocannabinoids in chronic migraine: CSF findings suggest a system failure

PINI, Luigi Alberto;
2007-01-01

Abstract

Based on experimental evidence of the antinociceptive action of endocannabinoids and their role in the modulation of trigeminovascular system activation, we hypothesized that the endocannabinoid system may be dysfunctional in chronic migraine (CM). We examined whether the concentrations of N-arachidonoylethanolamide (anandamide, AEA), palmitoylethanolamide (PEA), and 2-arachidonoylglycerol (2-AG) in the CSF of patients with CM and with probable CM and probable analgesic-overuse headache (PCM + PAOH) are altered compared with control subjects. The above endocannabinoids were measured by high-performance liquid chromatography ( HPLC), and quantified by isotope dilution gas-chromatography/mass-spectrometry. Calcitonin gene-related peptide (CGRP) levels were also determined by RIA method and the end products of nitric oxide (NO), the nitrites, by HPLC. CSF concentrations of AEA were significantly lower and those of PEA slightly but significantly higher both in patients with CM and PCM + PAOH than in nonmigraineur controls (p < 0.01 and p < 0.02, respectively). A negative correlation was found between AEA and CGRP levels in CM and PCM + PAOH patients (r=0.59, p < 0.01 and r=-0.65, p < 0.007; respectively). A similar trend was observed between this endocannabinoid and nitrite levels. Reduced levels of AEA in the CSF of CM and PCM + PAOH patients may reflect an impairment of the endocannabinoid system in these patients, which may contribute to chronic head pain and seem to be related to increased CGRP and NO production. These findings support the potential role of the cannabinoid (CB) 1 receptor as a possible therapeutic target in CM.
32
6
1384
1390
Endocannabinoids in chronic migraine: CSF findings suggest a system failure / P., Sarchielli; Pini, Luigi Alberto; F., Coppola; C., Rossi; A., Baldi; M. L., Mancini; P., Calabresi. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - STAMPA. - 32:6(2007), pp. 1384-1390. [10.1038/sj.npp.1301246]
P., Sarchielli; Pini, Luigi Alberto; F., Coppola; C., Rossi; A., Baldi; M. L., Mancini; P., Calabresi
File in questo prodotto:
File Dimensione Formato  
Pini.pdf

non disponibili

Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 172.74 kB
Formato Adobe PDF
172.74 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/612454
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 97
  • ???jsp.display-item.citation.isi??? 93
social impact